Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares Outstanding
Ratios

Fulcrum Therapeutics (FULC) Long-Term Debt Repayments: 2019-2021

Historic Long-Term Debt Repayments for Fulcrum Therapeutics (FULC) over the last 3 years, with Dec 2021 value amounting to $1,000.

  • Fulcrum Therapeutics' Long-Term Debt Repayments fell 92.31% to $1,000 in Q4 2021 from the same period last year, while for Dec 2021 it was $18,000, marking a year-over-year decrease of 64.00%. This contributed to the annual value of $18,000 for FY2021, which is 64.00% down from last year.
  • Latest data reveals that Fulcrum Therapeutics reported Long-Term Debt Repayments of $1,000 as of Q4 2021, which was up 200.00% from -$1,000 recorded in Q3 2021.
  • Fulcrum Therapeutics' Long-Term Debt Repayments' 5-year high stood at $13,000 during Q3 2019, with a 5-year trough of -$1,000 in Q3 2021.
  • In the last 3 years, Fulcrum Therapeutics' Long-Term Debt Repayments had a median value of $11,500 in 2019 and averaged $9,417.
  • Per our database at Business Quant, Fulcrum Therapeutics' Long-Term Debt Repayments increased by 20.00% in 2020 and then plummeted by 107.69% in 2021.
  • Fulcrum Therapeutics' Long-Term Debt Repayments (Quarterly) stood at $11,000 in 2019, then climbed by 18.18% to $13,000 in 2020, then plummeted by 92.31% to $1,000 in 2021.
  • Its Long-Term Debt Repayments stands at $1,000 for Q4 2021, versus -$1,000 for Q3 2021 and $5,000 for Q2 2021.